Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose crossover study of experimental levodopa/carbidopa/entacapone regimens versus Stalevo in Parkinson's disease with wearing-off
2010-022915-21Phase 2Completed
- Sponsor
- Orion Corporation
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of levodopa, carbidopa and entacapone in Parkinson's disease (PD) (3 arms), sponsored by Orion Corporation. Primary endpoint: Duration of motor response to levodopa (ON-time). Started Nov 2010; status: completed.
02
Drugs
levodopacarbidopaentacapone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2010-022915-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022915-21.